companydata.dkVesper Bio ApS: Financial statements 2016
CVR: 32879861
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -4,003,407 compared with DKK -6,065,152 the year before. Equity amounted to DKK 3,065,722. The solvency ratio was 76.5%.
- Profit/Loss
- -4,003,407 kr.
- Equity
- 3,065,722 kr.
- Total Assets
- 4,009,784 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -4 mio. | 3.1 mio. | - |
| 2015 | - | - | -6.1 mio. | 7.1 mio. | - |
| 2014 | - | - | -6.9 mio. | 5.6 mio. | - |
| 2013 | - | - | -2.6 mio. | 12.6 mio. | - |
| 2012 | - | -22 t. | -16 t. | 377 t. | - |
How creditworthy is Vesper Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
Vesper Bio ApS has published its annual report for 2015. The net result was DKK -6,065,152.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees. In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity amounted to DKK -227,433,239.